ArticleClinical ophthalmology (Auckland, N.Z.)2024

Efficacy of an Indian Bevacizumab BIOSimilar (BEVATAS) for Type 1 and Aggressive Posterior Retinopathy of Prematurity (BIOS-ROP Study).

Somnath Chakraborty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.